Aglaia

Aglaia invests in oncology drug development companies, from early-stage to clinical trials. With decades of cancer research expertise, it supports startups strategically, focusing on R&D planning and execution. Global reach.

Funding Stage: Series C & Beyond

Investor type: VC Firm

Investment Areas: Drugs aimed at treating cancer

Country: Netherlands